Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline Add-on to Losartan in Diabetic Nephropathy
NCT03006952Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pentoxifylline in diabetic nephropathy (DN), sponsored by Tehran University of Medical Sciences. Started Apr 2015; status: completed.
02
Drugs
pentoxifylline
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT03006952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006952.